Trial
NCT03553875
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Autism
Intervention
Memantine Hydrochloride
Why stopped
requested by the IRB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-25